We recently spoke with Carl Cook, Vice President of Clinical Operations at Black Diamond Therapeutics, a biotech focused on the discovery and development of precision medicines for cancer. The company is based in Cambridge, MA. We wanted to share these excerpts from the conversation:
What are the biggest and/or most common
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based in Morrisville, North Carolina, that focuses on identifying, developing, and commercializing products to address cardiovascular and pulmonary diseases. We wanted to share these excerpts from the conversation:
You’ve talked about the importance of telling your story. Can you expound on that?
At Tenax therapeutics, we're
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech focused on developing personalized, tumor-targeted immunotherapies. The company is based in Plymouth Meeting, PA. We wanted to share these excerpts from the conversation:
What are the biggest and/or most common challenges you meet with during the
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical research service provider specializing in patient-focused trial designs, often with at-home visit support. We wanted to share these excerpts from the conversation:
What do you see as the biggest or most common challenges to preparation for,
I had the pleasure of being interviewed on ReachMD as a part of their lifelong learning series. In this short interview topics range from Khan Academy to coaching to personal learning networks to doom loops in learning.
(And please pardon the unsightly picture of my throat, apparently SoundCloud's embed functionality is